Suppr超能文献

卡泊芬净对白色念珠菌和近平滑念珠菌生物膜的抗代谢活性。

Anti-metabolic activity of caspofungin against Candida albicans and Candida parapsilosis biofilms.

作者信息

Cocuaud Christophe, Rodier Marie-Hélène, Daniault Gyslaine, Imbert Christine

机构信息

Laboratoire de Parasitologie et Mycologie Médicales, Centre Hospitalier Universitaire La Milétrie, BP 577, 86021 Poitiers Cedex, France.

出版信息

J Antimicrob Chemother. 2005 Sep;56(3):507-12. doi: 10.1093/jac/dki269. Epub 2005 Jul 22.

Abstract

OBJECTIVES

Candidiasis can be associated with the formation of biofilms on bioprosthetic surfaces and the intrinsic resistance of Candida albicans biofilms to the most commonly used antifungal agents has been demonstrated. In this study, we report on the antifungal activity of caspofungin at two different concentrations, on C. albicans and Candida parapsilosis biofilms with different ages of maturation.

METHODS

Fifteen strains of C. albicans (10 strains susceptible to fluconazole in vitro and five strains resistant to this antifungal agent) and six strains of C. parapsilosis (all were susceptible to fluconazole in vitro) were studied. The antifungal activity of caspofungin was assessed by looking for a significant inhibition of the metabolic activity of yeasts within biofilms. Biofilms of Candida were produced in vitro, on silicone catheters.

RESULTS

Caspofungin used at MIC did not modify the metabolic activity of C. albicans, whatever the maturation age of the biofilms. The same concentration of caspofungin significantly reduced the metabolism (P<or=0.001) of 25% (biofilms of 48 h) to 50% (biofilms of 2 h) of the C. parapsilosis yeasts. The use of a therapeutic concentration of caspofungin (2 mg/L) significantly decreased (P<or=0.001) the metabolism of all the strains of C. albicans and C. parapsilosis tested, independently of the biofilm maturation age. This potent antifungal activity of caspofungin on C. albicans biofilms was observed independently of the yeast susceptibility to fluconazole.

CONCLUSIONS

This study demonstrated that caspofungin used at MIC was not sufficient to reduce C. albicans biofilms, but it suggested an activity on C. parapsilosis biofilms depending on their maturation age. This study also indicated that caspofungin used at 2 mg/L could be a good candidate in the prevention of candidiasis associated with silicone medical devices. Our results also suggested that fluconazole resistance of yeasts did not affect caspofungin activity.

摘要

目的

念珠菌病可能与生物假体表面生物膜的形成有关,并且白色念珠菌生物膜对最常用抗真菌药物的固有耐药性已得到证实。在本研究中,我们报告了两种不同浓度的卡泊芬净对不同成熟龄的白色念珠菌和近平滑念珠菌生物膜的抗真菌活性。

方法

研究了15株白色念珠菌(10株体外对氟康唑敏感,5株对该抗真菌药耐药)和6株近平滑念珠菌(所有菌株体外对氟康唑敏感)。通过观察对生物膜内酵母代谢活性的显著抑制来评估卡泊芬净的抗真菌活性。念珠菌生物膜在体外硅酮导管上产生。

结果

无论生物膜的成熟龄如何,以最低抑菌浓度(MIC)使用卡泊芬净均未改变白色念珠菌的代谢活性。相同浓度的卡泊芬净使近平滑念珠菌酵母的代谢显著降低(P≤0.001),降低幅度为25%(48小时生物膜)至50%(2小时生物膜)。使用治疗浓度的卡泊芬净(2mg/L)显著降低了(P≤0.001)所有测试的白色念珠菌和近平滑念珠菌菌株的代谢,与生物膜成熟龄无关。观察到卡泊芬净对白色念珠菌生物膜的这种强效抗真菌活性与酵母对氟康唑的敏感性无关。

结论

本研究表明,以MIC使用卡泊芬净不足以减少白色念珠菌生物膜,但提示其对近平滑念珠菌生物膜的活性取决于其成熟龄。本研究还表明,2mg/L的卡泊芬净可能是预防与硅酮医疗器械相关的念珠菌病的良好候选药物。我们的结果还表明,酵母对氟康唑的耐药性不影响卡泊芬净的活性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验